Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure-Reference-Cited by-同舟云学术

Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure

Published:2019-10 Issue: Volume:85 Page:106192
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Stratmann Jan^ORCID,van Kann Elisabeth,Rummelt Christoph,Koschade Sebastian,Röllig Christoph^ORCID,Lübbert Michael,Schaich Markus,Parmentier Stefani,Sebastian Martin,Chromik Joerg,Becker von Rose Aaron,Ballo Olivier^ORCID,Steffen Björn,Serve Hubert,Brandts Christian,Shaid Shabnam

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference44 articles.

1. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982);McCulloch;Blood,1983

2. Survival in patients with acute myeloblastic leukemia in Germany and the United States: major differences in survival in young adults;Pulte;Int. J. Cancer,2016

3. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;J. Clin. Oncol.,2005

4. Age and acute myeloid leukemia: Real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry;Juliusson;Blood,2009

5. Management of acute myeloid leukemia in elderly patients;Hiddemann;J. Clin. Oncol.,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Akute Leukämien;Facharztwissen Hamatologie Onkologie;2024

2. Pathogenic DDX41 variants, possible response predictors to low‐dose melphalan in hypo‐ and normocellular MDS and AML;British Journal of Haematology;2023-11-28

3. Juvenile exposure and adult risk assessment with single versus repeated exposure of melphalan in the germ cells of male SD rat: Deciphering the molecular mechanisms;Reproductive Toxicology;2022-10

4. Molecular Signatures in Acute Myeloid Leukemia: From Diagnosis to Targeted Therapy and Drug Repositioning;Interdisciplinary Cancer Research;2022

5. Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid;Cancers;2021-04-29